
Corporate venture arm of Johnson & Johnson investing in healthcare companies from seed stage onwards

Venture fund investing in pre-seed to Series A startups, now focused on deep tech and AI

Begin Capital is a venture capital fund that backs startups from pre-seed to Series A. Its first phase began in 2020 and produced 28 investments across many industries. The second phase is dedicated to deep tech, artificial intelligence and the physical world.
Founders it describes as rule-challenging, ambitious and rigorous about business processes and performance targets. It invests only in ideas that have been tested and can be expressed in numbers. The mandate is global, with the European market of particular interest.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Begin Capital.
Similar listings buyers compare against this one.

Corporate venture arm of Johnson & Johnson investing in healthcare companies from seed stage onwards

Austin venture capital firm backing early-stage applied AI companies across North America

European venture capital firm backing founders building global software companies

Venture investor backing entrepreneurs building companies out of India

Seed and early-stage investment fund in Switzerland that also builds companies with founders

Venture firm run by former entrepreneurs giving operating support to portfolio startups in Asia

A privately funded Swiss foundation supporting the growth of Swiss startups into scale-ups

European angel fund backing pre-seed and seed technology startups and coaching founders to Series A
Everything here links back to the same verified catalogue. Pick your next stop.